Disseminated Intravascular Coagulation

Day H J Rao A. K. Evaluation of platelet function. Semin Haematol 1986; 23: 89–101.

Sakariassen K S Bolhuis P A Sixma J. J. Adhesion of human blood platelets to human artery subendothelium is mediated by factor VIII–von Willebrand factor bound to subendothelium. Nature 1979; 279: 636–38.

Leytin V L Gorbunova N A Misselwitz F. . Step by step analysis of adhesion of human platelets to a collagen surface. Throm Res 1984; 34: 51–63.

Bolhuis P A Sakariassen K S Sander H J . Binding of factor VIII–von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhanced spreading. J Lab Clin Med 1981; 97: 568–74.

Gastpar H. Collagen platelet interactions. Stuttgart: FK Schattauer, 1978.

Niija K. Hodson E. Bader R. . Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Blood 1987; 70: 475–83.

Broze G J Jr Leykem J E Schwartz B D . Purification of human brain tissue factor. J Biol Chem 1985; 255: 1242–47.

Nemerson Y. The tissue factor pathway of blood coagulation. Semin Haematol 1992; 29(3): 170–76.

Mann K G Krishnaswamy S. Lawson J. H. Surface dependent haemostasis. Semin Haematol 1992; 29(3): 213–26.

Broze G J Jr. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Haematol 1992; 29(3): 159–69.

Marcum J A McKenney J B Rosenberg R D . The acceleration of thrombin–antithrombin complex formation in hind quarters via naturally occurring heparin like molecules bound to the endothelium. J Clin Invest 1984; 74: 341–50.

Hofsteenge J. Taguchi H. Stone S. R. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. Biochem J 1986; 237: 243–51.

Esmon C T Owen W. G. Identification of an endothelial cofactor for thrombin catalysed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249–52.

Fulcher C A Gardiner J E Griffin J H Zimmerman T. S. Proteolytic inactivation of human factor VIII by activated protein C and its analogy with factor V. Blood 1984; 63: 486–89.

Wiman B. Collen D. Molecular mechanisms of physiological fibrinolysis. Nature 1978; 272: 549–50.

Verstrate M. Su C A P F Tanswell P. . Pharmacokinetics and effects of fibrinolytic and coagulation parameters of two doses of human recombinant tissue plasminogen activator in healthy volunteers. Throm Haemost 1986; 56: 1–11.

Sprengers E D Klu F. E. C. Plasminogen activator inhibitors. Blood 1987; 69: 381–87.

Weiss H. J. Turitto V T Baumgartner H R . Evidence for the presence of tissue factor activity on subendothelium. Blood 1989; 73: 968–75.

Bevilacqua M P Prober J S Majeen G P . IL-1 induces hiosynthesis and cell surface expression of procoagulant activity in human vascular cells. J Exp Med 1984; 160: 618–23.

Coloucci M. Balconi G. Lounzet R. . Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893–96.

Conkling P R Greenberg C S Weinberg J B . Tumour necrosis factor induces tissue factor like activity in human leukaemia cell line U 937 and peripheral blood monocytes. Blood 1992; 72: 128–33.

Gregory S A Morrisey J H Edgington T S . Regulation of tissue factor gene expression in monocyte procoagulant response to endotoxin. Mol Cell Biol 1989; 9: 2752–55.

Osterud B. Flagstead T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection. Throm Haemost 1983; 49: 5–7.

Nand S. Messmore H. Haemostasis in malignancy. Am J Haematol 1990; 35 44–55.

Egbring R. Schmidt W. Fuchs G. . Demonstration of granulocyte proteases in plasma of patients with acute leukaemia and septicaemia with coagulation defects. Blood 1977; 41: 219–31.

Nathwani A C Tuddenham E. G. D. Epidemiology of coagulation. Baillieres Clin Haematol 1992; 5(2): 383–439.

Radomski M W Palmer R M Moncada S. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Haematol 1987; 92: 639–46.

Spero J A Lewis J H Hasiba Y. Disseminated intravascular coagulation: Findings in 346 patients. Throm Haemost 1980; 43: 28–33.

Harlan J M Harker L A Reidy M A Gajdusek C M Schwartz S M Striker G. E. Endotoxin mediated bovine endothelial cell injury in vivo. Lab Invest 1983; 48: 269–74.

Nawroth P P Stern D. M. Modulation of endothelial cell haemostatic properties by tumour necrosis factor. J Exp Med 1986; 163: 740–45.

Nawroth P P Handley D A Esmon C T . IL-1 induces endothelial cell procoagulant whilst suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83: 3460–64.

More K L Andreoli S P Esmon N L . Endotoxin enhances tissue factor and suppresses thrombomodulin expression on human vascular endothelium in vitro J Clin Invest 1987; 79: 124–30.

Schleef R R Bevilacqua M P Sawdey M. . Cytokine activation of vascular endothelium. Effects on tissue plasminogen activator inhibitors. J Biol Chem 1988; 263: 5797–5803.

Emeis J J Kooistra T. . IL-1 and endotoxin induce an inhibitor of tissue plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986; 183: 1260–66.

Van Hinsbergh V W M Kooistra T. Van de Berg E A . TNF increases the production of plasminogen activator inhibitor–1 in human endothelial cells. Blood 1988; 72: 1467–73.

Schorer A E Moldow C F Rick M E . IL-1 or endotoxin increase release of von Willebrand factor from human endothelial cells. Br J Haematol 1987; 67: 193–97.

Bussolino F. Camussi G. Baglioni C. . Synthesis and release of platelet activating factor by human vascular endothelial cells treated with TNF or IL-1. J Biol Chem 1988; 263: 11856–61.

Brox J. H. Osterude B. Bjorklid E. . Production and availability of thromboplastin in endothelial cells. The effects of thrombin, endotoxin and platelets. Br J Haematol 1984; 57: 239–46.

Maniyama I. Bell C E Majerus P. W. Thrombomodulin is found in endothelium of arteries, veins, capillaries and lymphatics. J Cell Biol 1985; 101: 363–71.

Gelehrter T D Sznycer-Laszuk R. Thrombin induction of plasminogen activator inhibitor 1 in cultured human endothelial cells. J Clin Invest 1986; 77: 165–69.

Gimbrone M A Obin M S Brock A F . Endothelial IL-8: Novel inhibitor of endothelial leucocyte interaction. Science 1989; 246: 1601–603.

Bevilacqua M P Stengelin S. Gimbrone M A . ELAM-1: An inducible receptor to complement regulatory proteins. Science 1989; 243: 1160–65.

Geng J G Bevilacqua M P Moore K L . Rapid neutrophil adhesion to activated endothelium is mediated via GMP-140. Nature 1990; 343: 757–60.

Hogg N. Leucocyte integrins. Immunol Today 1990; 1(4): 111–14.

Schmidt W. Egbring R. Havemann K. . Effect of elastase and chymotrypsin like neutral proteases from human neutrophils on isolated clotting factors. Thromb Res 1975; 6: 315–29.

Sacks T. Moldow C F Craddock P R Bowers T K Jacob H. S. Oxygen radicals mediate endothelial cell damage by stimulated granulocytes. J Clin Invest 1978; 61: 1161–67.

Weiss S. Tissue destruction by neutrophils. N Eng J Med 1989; 320: 365–76.

Glaser C A Morar J. Clarke J H . Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks its cofactor activity. J Clin Invest 1992; 90: 2565–73.

Edwards R L Rickles F. R. Role of leucocytes in the activation of blood coagulation. Semin Haematol 1992; 29(3): 202–212.

Muller-Berghaus G. Boln E. Hobel W. . Activation of disseminated intravascular coagulation by endotoxin: The significance of neutrophils and platelets. Br J Haematol 1976; 33: 213–20.

Palabrica T. Lobb R. Furie B C . Leucocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359: 848–51.

Nilsson I. M. Assessment of blood coagulation and general haemostasis. In: Bloom A L Thomson D P eds. Haemostasis and thrombosis. Edinburgh: Churchill Livingstone, 1987: 926.

Carr J M McKinney M. McDonagh J. Diagnosis of disseminated intravascular coagulation: Role of D-dimer. Am J Clin Pathol 1989; 91: 280–87.

Visudhiphan S. Piankijagum A. Sathayapraseart P. Erythrocyte fragmentation in disseminated intravascular coagulation and other diseases. N Eng J Med 1983; 309: 113.

Kobayashi T. Teraco T. Pre-eclampsia as chronic disseminated intravascular coagulation. Study of thrombin–antithrobin III complexes and D-dimers. Gynecol Obstet Invest 1987; 24: 170–78.

Harpel P. Alpha-2-plasmin inhibitor and alpha-2 macroglobulin–plasmin complexes in plasma. J Clin Invest 1981; 68: 46–55.

Bick R. Bick M. Fekete L. Antithrombin III patterns in disseminated intravascular coagulation. Am J Clin Pathol 1980; 73: 577–83.

Sheth S B Carvallo A. C. Protein S and protein C alterations in acutely ill patients. Am J Haematol 1991; 36: 14–19.

Fourrier F. Lestavel P. Chopin C. . Meningococcaemia and purpura fulminans in adults, acute deficiencies of protein C and S with early treatment with antithrombin III concentrates. Intens Care Med 1990; 16: 121–24.

Risberg B. Medegard A. Heideman M. . Early activation of humoral proteolytic systems in patients with multiple trauma. Crit Care Med 1986; 14 917–25.

Nossel H L Yuddman I. Canfield R E . Measurement of fibrinopcptide A in human blood. J Clin Invest 1974; 54: 43–53.

Risberg B. Andreasson S. Eriksson E. Disseminated intravascular coagulation. Acta Anaesth Scand 1991; 35 (suppl 95): 65–71.

Williams E. Plasma alpha-2-antiplasmin activity: Role in the evaluation of fibrinolytic states and other bleeding disorders. Arch Intern Med 1989; 149: 1769–72.

Nand S. Fisher S G Salgia R. Fisher R. I. Haemostatic abnormalities in untreated cancer. Incidence and correlation with thrombotic or haemorrhagic complications. J Clin Oncol 1987; 5: 1998–2003.

Rickles F R Edwards R. L. Activation of blood coagulation in cancer. Trousseau's syndrome revisited. Blood 1983; 62: 14–31.

Falanga A. Alessio M G Donati M. B. A new procoagulant in acute leukaemia. Blood 1988; 71: 870–75.

Kwaan H C Kear H. N. Fibrinolysis and cancer. Semin Throm Haemost 1990; 16(3): 230–34.

Honneger H. Anderson N. Hewitt L. A. Antithrombin III profiles in malignancy. Relationship to primary tumours and metastatic sites. Thromb Haemost 1981; 46: 500–503.

Tallmann M S Kwaan H. C. Reassessing the haemostatic disorder associated with acute promyelocytic leukaemia. Blood 1992; 79(3): 543–53.

Bone R. Francis F. Pierce A. Disseminated intravascular coagulation associated with acute adult respiratory distress syndrome. Am J Med 1976; 61 585–89.

Vesconi S. Rossi G. Presenti A. . Pulmonary microthrombosis in severe adult respiratory distress syndrome. Crit Care Med 1988; 16: 111–13.

De Boer R. Ten Cate J. Sturk A. . Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gyn 1989; 160: 95–100.

Alperin J. Coagulopathy caused by vitamin K deficiency in critically ill hospitalized patients. J Am Med Assoc 1987; 258: 1916–19.

British Committee for Standards in Haematology. Guidelines for the use of fresh frozen plasma. Transfus Med 1992; 2: 57–63.

British Committee for Standards in Haematology. Guidelines for platelet transfusion Transfus Med 1992; 2: 311–18.

Feinstein D. Treatment of disseminated intravascular coagulation. Semin Thromb Haemost 1983; 14: 351.

Garewich V. Lipinski B. Low dose heparin in treatment of disseminated intravascular coagulation. Am J Med Sci 1977; 274: 83.

Hatch R L Barke J I Barke M. W. Coagulopathy associated with dilatation and evacuation for intrauterine death. Obstet Gynecol 1985; 56: 563.

Rodeghiero F. Avvisati G. Castaman G. . Early deaths and anti-haemorrhagic treatments in acute promyelocytic leukaemia. A GIMEMA retrospective study in 268 consecutive patients. Blood 1990; 75: 2112.

Le Veen H. Ahmed N. Hutto R. . Coagulopathy post Le Veen shunt. Ann Surg 1987; 205: 305–11.

Mammen E. Miyakawa T. Phillips T. . Human antithrombin III and experimental disseminated intra- vascular coagulation. Semin Thom Haemost 1985; 11: 373.

Schipper H. Jenkins C. Kahle L. Ten Cate J. Antithrombin III transfusion in disseminated intravascular coagulation. Lancet 1978; i: 854–56.

Redens T B Emerson T E Jr. Antithrombin III treatment inhibits disseminted intravascular coagulation. Circ Shock 1989; 28: 49–58.

Swartholm E. Haglund U. Ljungberg J. Influence of aprotinin on porcine E. coli shock: Studies on coagulation, fibrinolytic and haemodynamic responses. Acta Chir Scand 1989; 155: 7–13.

Colman R W Flores D N Cadena R A . Recombinant alpha-1 antithrombin Pittsburgh attenuates experimental Gram negative septicaemia. Am J Pathol 1988; 130: 418–26.

Maruyama I. Okadome T. Sinmyouzu K. . Consumption of endothelial cell surface thrombomodulin in endotoxin induced disseminated intravascular coagulation in rats and its improvement by infusion of recombinant human thrombomodulin. Blood 1990; 76 (suppl 1): 4290.

Tracey K J Fung Y. Hesse D G . Anti-TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330: 662–64.

Day K C Hoffman L C Palmier M O . Recombinant tissue factor pathway inhibitor inhibits tissue thromboplastin induced disseminated intravascular coagulation in rabbits. Blood 1990; 76: 1538–45.